Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients [4]

Schizophrenia Research

Volumn 66, Issue 2-3, 2004, Pages 197-198

  Mauri, Massimo C ^a   Volonteri, Lucia S ^a   Fiorentini, Alessio ^a   Invernizzi, Giordano ^a   Nerini, Teresa ^b   Baldi, Marialuisa ^b   Bareggi, Silvio R ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; NORCLOZAPINE; PSYCHOTROPIC AGENT;

BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; GENERAL CONDITION IMPROVEMENT; HUMAN; LETTER; MENTAL PATIENT; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0346731080     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00159-2     Document Type: Letter

References (6)

1. Dettling M., Sachse C., Brockmöller J., Schley J., Müller-Oerlinghausen B., Pickersgill I., Rolfs A., Schaub R.T., Schmider J. Long-term drug monitoring of CLZ and metabolites in psychiatric in- and outpatients. Psychopharmacology. 152:2000;80-86.
2. Lieberman J.A., Safferman A.Z., Pollack S., Szymanski S., Johns C., Howard A., Kronig M., Bookstein P., Kane J.M. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am. J. Psychiatry. 151:1994;1744-1752.
3. Mauri M.C., Rudelli R., Bravin S., Gianetti S., Giuliani E., Guerrini A., Orlandi R., Invernizzi G. Clozapine metabolism rate as a possible index of drug-induced granulocytopenia. Psychopharmacology. 137:1998;341-344.
4. Olesen O.V. Therapeutic drug monitoring of clozapine treatment: therapeutic threshold value for serum clozapine concentrations. Clin. Pharmacokinet. 34:1998;497-502.
5. Spina E., Avenoso A., Facciolà G., Scordo M.G., Ancione M., Madia A.G., Ventimiglia A., Perucca E. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics. Psychopharmacology. 148:2000;83-89.
6. Van der Zwaag C., McGee M., McEvoy J.P., Freudenreich O., Wilson W.H., Cooper T.B. Response of patients with treatment-resistant schizophrenia to clozapine within three serum level ranges. Am. J. Psychiatry. 153:1996;1579-1584.